Onderneming MELA Sciences Inc Nasdaq
Aandelen
US55277R3084
Geavanceerde medische apparatuur & technologie
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Dermatology Recurring Procedures
64,5
%
| 23 | 63,7 % | 22 | 64,5 % | -6,49% |
Dermatology Procedures Equipment
35,5
%
| 13 | 36,3 % | 12 | 35,5 % | -9,96% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
69,0
%
| 24 | 66,3 % | 23 | 69,0 % | -3,97% |
Other Foreign
12,8
%
| 4 | 10,3 % | 4 | 12,8 % | +14,79% |
China
10,0
%
| 5 | 13,1 % | 3 | 10,0 % | -29,70% |
South Korea
8,2
%
| 4 | 10,3 % | 3 | 8,2 % | -26,59% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Dolev Rafaeli
CEO | Chief Executive Officer | 60 | 10-04-18 |
Director of Finance/CFO | 42 | 06-07-21 | |
Shmuel Gov
COO | Chief Operating Officer | - | 01-01-15 |
Amandeep Kaur
SAM | Sales & Marketing | - | 04/12 |
Brent Cowgill
SAM | Sales & Marketing | - | 02-08-21 |
John Bagdasarian
PRN | Corporate Officer/Principal | - | 14-03-22 |
Jay Sturm
LAW | General Counsel | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Patricia Walker
BRD | Director/Board Member | 64 | 14-02-22 |
Uri Geiger
CHM | Chairman | 56 | 29-05-18 |
Homi Shamir
BRD | Director/Board Member | 70 | - |
Director/Board Member | 57 | 12-04-21 | |
Dolev Rafaeli
CEO | Chief Executive Officer | 60 | 10-04-18 |
Director/Board Member | 59 | 29-05-18 | |
Director/Board Member | - | 27-10-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 35 060 954 | 20 829 402 ( 59,41 %) | 0 | 59,41 % |
Bedrijfsgegevens
STRATA Skin Sciences, Inc.
5 Walnut Grove Drive Suite 140
19044, Horsham
+215 619 3200
http://www.strataskinsciences.comSector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+12,85% | 229 mld. | |
+13,88% | 195 mld. | |
+18,39% | 142 mld. | |
+28,78% | 109 mld. | |
+1,67% | 64,85 mld. | |
+18,24% | 54,33 mld. | |
+7,04% | 52,09 mld. | |
+10,83% | 45,15 mld. | |
+5,94% | 37,39 mld. |